Advancements in CRISPR-Cas9 for Cancer Therapy

Authors

  • Kim Davis
  • Ella Nelson
  • Robin Lewis

Keywords:

CRISPR-Cas9, cancer therapy, gene editing, oncology, personalized medicine

Abstract

This article explores the revolutionary use of CRISPR-Cas9 gene-editing technology in cancer treatment. It delves into recent case studies where CRISPR has successfully targeted and modified genetic mutations driving cancer progression. The potential benefits and ethical implications are also discussed, highlighting CRISPR's role in personalized medicine. This overview provides insights into the future of gene therapy, emphasizing its transformative impact on oncology and patient care.

Author Biographies

Kim Davis

PhD
Harvard University
Massachusetts Hall, Cambridge, MA 02138, USA

Ella Nelson

PhD
University of Oxford
University Offices, Wellington Square, Oxford OX1 2JD, UK

Robin Lewis

MD
Charité – Universitätsmedizin Berlin
Charitéplatz 1, 10117 Berlin, Germany

References

Viroliya, K., Hojjat, A., Pena, B., Bhatt, H., Mehta, N. N., Venkata, S. Y., ... & Palabindela, P. (2023). Sa1359 HELICOBACTER PYLORI ASSOCIATED GASTRO-INTESTINAL BLEEDING IN BARIATRIC SURGERY-NATIONWIDE SURREY. Gastroenterology, 164(6), S-373.

Downloads

Published

2025-12-23

Issue

Vol. 3 No. 4 (2025)

Section

Articles